Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

ARCA Biopharma Inc

ABIO
28,80
0,00 (0,00%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/8/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202422:50GLOBEARCA biopharma Announces Completion of Merger with Oruka..
27/8/202401:30GLOBEARCA biopharma Provides Update Regarding Special Dividend..
23/8/202422:35EDGAR2Form 8-K - Current report
23/8/202422:30GLOBEARCA biopharma Announces 1-for-12 Reverse Stock Split in..
20/8/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:27EDGAR2Form 425 - Prospectuses and communications, business..
16/8/202422:25EDGAR2Form 8-K - Current report
16/8/202422:15GLOBEARCA biopharma Declares Special Dividend in Connection with..
15/8/202422:17EDGAR2Form 425 - Prospectuses and communications, business..
15/8/202422:15EDGAR2Form 8-K - Current report
09/8/202414:35EDGAR2Form 425 - Prospectuses and communications, business..
01/8/202422:30EDGAR2Form 425 - Prospectuses and communications, business..
01/8/202422:25EDGAR2Form 8-K - Current report
01/8/202422:15GLOBEARCA biopharma Announces Second Quarter 2024 Financial..
01/8/202422:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/7/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/7/202423:17EDGAR2Form S-4/A - Registration of securities, business..
13/7/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202401:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/7/202423:29EDGAR2Form S-4/A - Registration of securities, business..
09/7/202423:04EDGAR2Form 425 - Prospectuses and communications, business..
09/7/202423:01EDGAR2Form 8-K - Current report
05/7/202423:20EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
18/6/202423:17EDGAR2Form S-4/A - Registration of securities, business..
06/6/202422:45EDGAR2Form 425 - Prospectuses and communications, business..
22/5/202421:08PRNUSKuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to..
25/4/202422:15GLOBEARCA biopharma Announces First Quarter 2024 Financial..
05/4/202419:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202413:30GLOBEARCA biopharma and Oruka Therapeutics Announce Merger..
07/2/202419:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:15EDGAR2Form 8-K - Current report
01/2/202422:39EDGAR2Form 8-K - Current report
01/2/202422:35GLOBEARCA biopharma Announces 2023 Financial Results
01/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/2/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:15EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 28,80

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network